Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07488819 · ClinicalTrials.gov registry record
Imaging Phosphodiesterase 4B (PDE4B) in People With Psychiatric Disorders With Positron Emission Tomography (PET) and the Radiotracer [18F]PF974
A clinical trial, sponsored by Yale University.
- Recruiting
- Registry status
- 160
- Enrollment target
NCT07488819 is a clinical trial that is actively recruiting participants, run by Yale University. The registered enrollment target is 160 participants.
The verdict
NCT07488819 is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 160 participants
- Enrollment target
Study Summary
Imaging PDE4B in people with psychiatric disorders with PET and the radiotracer \[18F\]PF974
Interventions
- DRUG PF974
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2025-07-07 |
| Est. Completion | 2032-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07488819
The ClinicalTrials.gov registry entry for NCT07488819 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PF974 is the first listed.
NCT07488819 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07488819 about?
NCT07488819 is a clinical study titled "Imaging Phosphodiesterase 4B (PDE4B) in People With Psychiatric Disorders With Positron Emission Tomography (PET) and the Radiotracer [18F]PF974". Imaging PDE4B in people with psychiatric disorders with PET and the radiotracer \[18F\]PF974
What is the current status of trial NCT07488819?
This trial is currently recruiting. The enrollment target is 160 participants. The study started on 2025-07-07. Estimated completion is 2032-03-01.
What interventions are being tested in trial NCT07488819?
The interventions under investigation include: PF974 (DRUG).
Who is sponsoring clinical trial NCT07488819?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.